Viewing Study NCT01770795


Ignite Creation Date: 2025-12-24 @ 1:40 PM
Ignite Modification Date: 2026-04-13 @ 4:50 PM
Study NCT ID: NCT01770795
Status: COMPLETED
Last Update Posted: 2013-01-18
First Post: 2013-01-16
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase II Trial of Genexol-PM and Gemcitabine in Patients With Advanced Non-small-cell Lung Cancer
Sponsor: Gachon University Gil Medical Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module